Reference
Ciampi E, et al. Real-world evidence of immune reconstitution therapies: Use of cladribine and alemtuzumab in chile. Multiple Sclerosis Journal 28: abstr. 0031, No. 2, 2022. Available from: URL: http://doi.org/10.1177/13524585211052173 [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab/cladribine. Reactions Weekly 1898, 29 (2022). https://doi.org/10.1007/s40278-022-11622-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-11622-9